Press Releases
Search
-
26 Feb 2014
bioMérieux strengthens its Clostridium difficile offer with the launch of VIDAS® C. difficile GDH
VIDAS® C. difficile GDH is the 100th assay for use on VIDAS® range VIDAS® C. difficile GDH is the only FDA-approved automated immunoassay parameter for GDH* detection * Glutamate dehydrogenase...
-
19 Feb 2014
BioFire Submits 510(k) Application to FDA for FilmArray® Gastrointestinal Panel
BioFire Diagnostics, LLC today announced that it has submitted the FilmArray Gastrointestinal (GI) Panel to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The comprehensive FilmArra...
-
27 Jan 2014
Appointment of Claire Giraut as bioMérieux’s Corporate Vice President & Chief Financial Officer
Marcy l’Etoile, France, January 27, 2014 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that Claire Giraut has been appointed Corporate Vice President & Chief Financial O...
-
22 Jan 2014
Business Review for the year ended December 31, 2013
2013: solid 4.6% organic growth in sales At the top end of the target range announced early in the year Faster organic growth in North America and firmer business in Western Europe Sustained fast grow...
-
16 Jan 2014
bioMérieux finalizes acquisition of the U.S. company BioFire, specialized in molecular biology
Marcy l'Etoile, France, January 16, 2014 - bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has finalized its acquisition of 100% ownership in BioFire Diagnostics Inc...
-
05 Dec 2013
bioMérieux is Moving Forward to a New Molecular Biology Workflow Solution for Reference or Centralized Laboratories
Marcy l'Étoile, France, December 5th, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, has announced that it is moving a new step forward to its comprehensive automation solutio...